
Bioidentical V.S. Non-Bioidentical Hormones
The Gillett Health Podcast
Practical Issues Finding Specific Formulations
James and Dan discuss patch availability (Vivelle) and pharmacy variability when prescribing specific products.
James O'Hara sits down with Dr Dan Bristow (OB-GYN) to talk about hormones
For High-quality labs:
► http://sagebio.com/
For information on the Gillett Health clinic, lab panels, and health coaching:
► https://GillettHealth.com
Follow Gillett Health for more content from James and Kyle
► https://instagram.com/gilletthealth
► https://www.tiktok.com/@gilletthealth
► https://twitter.com/gilletthealth
► https://www.facebook.com/gilletthealth
Follow Kyle Gillett, MD
► https://instagram.com/kylegillettmd
Follow James O’Hara, NP
► https://Instagram.com/jamesoharanp
For 10% off Gorilla Mind products, including SIGMA: Use code “GH10”
► https://gorillamind.com/
For discounts on high-quality supplements
►https://www.thorne.com/u/GillettHealth
►Compiled Source List
Systematic and Narrative Reviews
1. Gut microbial β‑glucuronidase: a vital regulator in female estrogen metabolism and gynecologic cancers
PMCID: PMC10416750
• Year: 2023
• Journal: International Journal of Molecular Sciences
• Summary: Reviews role of β-glucuronidase in estrogen metabolism, breast cancer, endometriosis.
2. A New Paradigm in Gut Microbiota & Breast Cancer: β‑Glucuronidase as Therapeutic Target
DOI: 10.3390/pathogens12091086
• Year: 2023
• Journal: Pathogens
• Summary: Emerging model proposing gmGUS as a direct target in estrogen-driven breast cancer.
3. Gut and oral microbiota in gynecologic cancers: mechanisms and therapeutic value
DOI: 10.1038/s41522-024-00577-7
• Year: 2024
• Journal: npj Biofilms and Microbiomes
• Summary: Systematic review on microbiota’s role in ovarian, cervical, and breast cancers.
Human Clinical or Case-Control Studies
4. Assessment of gut microbial β‑glucuronidase and β‑glucosidase activity in women with PCOS
PMCID: PMC10366212
• Year: 2023
• Journal: Scientific Reports
• Summary: Found significantly higher β-glucuronidase activity in PCOS patients.
5. Gut microbiota and ovarian diseases: a new therapeutic perspective
DOI: 10.1186/s13048-025-01684-5
• Year: 2025
• Journal: Journal of Ovarian Research
• Summary: Review covering PCOS, POI, and tumors—describes estrogen recycling via gut microbiota.
Mechanistic, In Vitro, and Animal Studies
6. In vitro analysis of gut microbial β‑glucuronidases and estrogen deconjugation
DOI: 10.1016/j.jbc.2020.105542
• Year: 2020
• Journal: Journal of Biological Chemistry
• Summary: Characterized 35 GUS enzymes that reactivate estrogen glucuronides.
7. Impact of intestinal flora on ovarian function and disease pathogenesis
Full text: e-century.us
• Year: 2024
• Journal: American Journal of Translational Research
• Summary: Animal studies showing how β-G-producing gut bacteria drive ovarian dysfunction.
8. The role of gut microbiota in endometriosis: current insights
DOI: 10.3389/fmicb.2024.1363455
• Year: 2024
• Journal: Frontiers in Microbiology
• Summary: Mechanistic review linking β-G-producing bacteria to lesion development and inflammation in endometriosis.
#female #femalehealth #hormones #testosterone
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy


